Endemic Dimorphic Fungi

I. Introduction: What are Dimorphic Fungi?

Certain highly pathogenic fungi exhibit Thermal Dimorphism, meaning a single fungal species can demonstrate two entirely different structural forms depending strictly on the temperature of their environment.

The Two Forms:

1. Mycelial (Mold) Form: Occurs in the free-living form in nature. Grown in the laboratory at 30°C (room temperature). They produce spores (conidia) which are the infectious particles.
2. Yeast-like Form: The parasitic phase found actively growing in human tissue. Grown in the laboratory at 35°C - 37°C (body temperature).

The Endemic Outline:
This module covers the major endemic dimorphic fungi: Histoplasmosis, Blastomyces, Coccidioides species, Paracoccidioides brasiliensis, Penicillium (Talaromyces) marneffei, and the Sporothrix schenckii complex.

---

II. Histoplasmosis: Ecology & Epidemiology

Habitat & Distribution:

• Present on every continent except Antarctica. Strongly associated with specific river valleys (e.g., the Ohio and Mississippi River Valleys in the USA).
• It is a soil-based fungus.
• Found directly in association with decaying bird and bat droppings (guano). Bats carry the fungus actively in their Gastrointestinal Tract (GIT) and shed it, keeping the soil heavily seeded.
• Favorable Soil Conditions: Requires a high nitrogen content (from the droppings), acidic pH, and moisture. Usually found within the top 20 cm of the soil surface.
• Climate factors: Temperature 22°C to 29°C, annual precipitation 35 to 50 inches, and relative humidity 67% to 87%.

Transmission & Risk Factors:

• Route of Entry: Inhalation of infectious particles into the lungs.
• Transmission occurs due to the disruption of the soil (e.g., by excavation or construction), which aerosolizes the spores.
• Populations at Risk: Spelunkers (cave explorers exposed to bat guano), agriculturalists, and outdoor construction workers.
• Transmission Limits: There is absolutely no human-to-human transmission via the pulmonary route.
• Male to female ratio is heavily skewed at 4:1 (likely due to occupational exposure differences).

---

III. Mycology of Histoplasma

Taxonomic Classification:
Kingdom: Fungi → Phylum: Ascomycota → Class: Eurotiomycetes → Order: Onygenales → Family: Ajellomycetaceae → Genus: Histoplasma.

• Heterothallic Form (Sexual stage): Designated as Ajellomyces capsulatum.
• Mating & Forms: Features Mating types (+) and (−). They produce fruiting bodies containing asci upon mating. Interestingly, clinical isolates from human patients overwhelmingly carry the (−) mating type.

The Mycelial Phase (Mold at Room Temp):

• Acts as a saprobe (lives on dead organic matter).
• Divided into two colony types: Brown (B) which generates a brown pigment, and Albino (A) which grows more rapidly in culture but loses the capability to produce spores after prolonged subculturing.
• Features two types of conidia (spores):
  1. Macroconidia: Large ovoid bodies (8–15 μm). They are heavily tuberculated (covered in thick, slender protrusions looking like a spiked club).
  2. Microconidia: Small, smooth oval bodies (2–5 μm). These are the infective forms! They are small enough to bypass the upper airways and lodge deep in the terminal bronchioles and alveoli.

The Yeast Phase (Parasitic at 37°C):

• Yeast cells derived from the "B" type colony are distinctly more virulent than those from the "A" type.

---

IV. The Physiology of Dimorphism

Dimorphism (the transition from the environmental mycelial phase to the parasitic yeast phase) is a critical step in the infectivity of the fungus. Without this transition, it cannot survive in the human body.

• The Stimulus & Sensor: The sole stimulus for the transition is Heat (37°C). This shift in temperature is sensed physically by a rapid change in the fluidity of the yeast cell membrane.
• Nutritional Requirements: Requires vitamins (thiamine, biotin), iron, cysteine, and calcium.
  • Cysteine: Strictly necessary for the maintenance of the yeast phase.
  • Calcium: Strictly necessary for the maintenance of the mycelial phase.

The Transition Cascade (When exposed to 37°C):

• Genetic Changes:
  • cdc2 is upregulated (involved in cell cycle progression).
  • yps-3 is upregulated (a yeast-specific gene).
  • Heat shock protein genes (especially hsp 70) are massively upregulated to survive the sudden host temperature.
  • Dimorphism is heavily associated with the upregulation of a Ca-binding protein. This protein acts as a calcium scavenger, synthesized by yeast cells to steal calcium from the host's calcium-poor intracellular environment.
• Biochemical Changes:
  • Uncoupling of oxidation-phosphorylation.
  • Initial decrease in RNA and protein synthesis.
  • Respiration becomes undetectable initially, then resumes once the yeast form is established.
• Physical Changes:
  • Enlargement of the yeast cells, losing their ovoid shape to become allomorphs.
  • These allomorphs contain less α-(1,3)-glucan in their cell walls, which leads to attenuated virulence, allowing the fungus to enter a state of dormancy or persistence in the host!

---

V. Pathogenesis & Host Immunity

Initial Infection & Dissemination:

1. Inhalation of microconidia → Settle into alveoli → Bind to the CD11/CD18 family of integrins on host cells → Engulfed by neutrophils and alveolar macrophages (MQS).
2. Inside the macrophage, the spore transforms into the yeast phase (Dimorphism).
3. The yeasts survive inside the macrophage and migrate intracellularly to local draining lymph nodes, then disseminate to distant organs rich in mononuclear phagocytes (the Reticuloendothelial System: Liver and Spleen).

Innate Immunity Evasion:

• Neutrophils (PMNs) emigrate early and release defensins, but the PMN respiratory burst has little or no effect on killing the fungus!
• Macrophages are the principal effector cells. Yeast entry into the MQS is actually aided by HSP60 expressed on the yeast surface.
• Physiology Expansion: Once inside the phagolysosome, the yeast evades intracellular killing by alkalizing the phagolysosome. By raising the pH, the host's destructive lysosomal enzymes (which require a highly acidic environment) are rendered completely useless!
• To survive, the yeast steals Iron and Calcium from the macrophage via siderophores, ferric reductase, and pH modulation to strip iron from host transferrin.
• HIV Note: MQS from HIV-infected individuals have defective activity. Yeasts grow much more rapidly within these compromised cells.

Adaptive Immunity (T-Cell Mediated):

• Cell-Mediated Immunity (CMI) is pivotal for clearance. T cells (CD4+ and CD8+) release cytokines (IFN-γ, IL-12, and TNF-α) that supercharge the macrophages to finally halt fungal multiplication (takes about 2 weeks).
• Even with strong CMI, the infection is rarely completely eliminated. Yeasts remain viable and dormant in tissues for many years, ready to reactivate if the host's immunity is ever compromised.

---

VI. Clinical Manifestations

Histoplasmosis presents in several distinct clinical syndromes, largely dependent on the host's immune status and the dose of inhaled spores.

• Acute Pulmonary Histoplasmosis: Often completely asymptomatic or presents as a mild flu. Resolves on its own.
• Acute Cavitary Pulmonary Disease: Severe symptoms including fever, productive cough, and chest pain. X-rays show cavitations similar to Tuberculosis.
• Progressive Disseminated Histoplasmosis (PDH): Occurs in the immunocompromised. Symptoms include fever, weight loss, massive hepatosplenomegaly (liver/spleen enlargement), and hematologic disturbances.
• Other Forms: Ocular Histoplasmosis (retinal scarring), Mediastinal granuloma/fibrosis, and African Histoplasmosis (caused by H. capsulatum var. duboisii).

Immunologic & Pathologic Manifestations Table Analysis:

---

VII. Laboratory Diagnosis & Treatment

Treatment & Prevention:

• Antifungals: Polyenes (Amphotericin B for severe/disseminated disease) and Azoles (Itraconazole for mild/step-down therapy).
• Prevention: Education for high-risk workers. When restoring buildings with bat/bird guano, use N95 masks, dust control, and spray a 3% formalin solution on the droppings to kill the fungus before removal.
• Vaccination (Research): Candidates containing heat shock protein 60 (specifically amino acids 174-445) and the H antigen confer protection in studies.

---

VIII. Recommended References

• World Health Organization (WHO): Guidelines on the Diagnosis and Management of Endemic Fungal Infections.
• Centers for Disease Control and Prevention (CDC): Histoplasmosis Fact Sheets and Occupational Exposure Guidelines.
• Infectious Diseases Society of America (IDSA): Clinical Practice Guidelines for the Management of Patients with Histoplasmosis.
• Medical Mycology Textbooks: Chapters covering Thermal Dimorphism in Endemic Mycoses.